{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:19:52Z","timestamp":1792757992185,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370805"],"award-info":[{"award-number":["32370805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970044"],"award-info":[{"award-number":["31970044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmc.2025.118521","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:47:38Z","timestamp":1765871258000},"page":"118521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel PROTACs with polyhedral alkanes as linkers for enhanced ALK degradation in drug-resistant NSCLC"],"prefix":"10.1016","volume":"134","author":[{"given":"Dongchen","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5196","key":"10.1016\/j.bmc.2025.118521_bb0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.267.5196.316.c","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-HODGKINS-lymphoma (vol 263, PG 1281, 1994)","volume":"267","author":"Morris","year":"1995","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.bmc.2025.118521_bb0010","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm2007613","article-title":"Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal\u2013epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)","volume":"54","author":"Cui","year":"2011","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.bmc.2025.118521_bb0015","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/jm400402q","volume":"56","author":"Marsilje","year":"2013","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118521_bb0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ccr.2011.04.004","article-title":"CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant","volume":"19","author":"Sakamoto","year":"2011","journal-title":"Cancer Cell"},{"issue":"8_Supplement","key":"10.1016\/j.bmc.2025.118521_bb0025","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1158\/1538-7445.AM2013-5655","article-title":"Abstract 5655: AP26113 possesses pan-inhibitory activity versus crizotinib-resistant ALK mutants and oncogenic ROS1 fusions","volume":"73","author":"Squillace","year":"2013","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.bmc.2025.118521_bb0030","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/jm500261q","volume":"57","author":"Johnson","year":"2014","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118521_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1078-0432.CCR-19-1104","article-title":"Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer","volume":"26","author":"Recondo","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118521_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2021.06.043","article-title":"Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non\u2013small-cell lung cancer: a multicenter study using targeted next-generation sequencing","volume":"156","author":"Lin","year":"2021","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.bmc.2025.118521_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/acsptsci.2c00142","article-title":"Proteolysis targeting chimeras (PROTACs): a perspective on integral membrane protein degradation","volume":"5","author":"Ruffilli","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.bmc.2025.118521_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103417","article-title":"PROTACting the kinome with covalent warheads","volume":"28","author":"Chatterjee","year":"2023","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.bmc.2025.118521_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ymthe.2022.11.011","article-title":"PROTAC therapy as a new targeted therapy for lung cancer","volume":"31","author":"Li","year":"2023","journal-title":"Mol Ther"},{"issue":"21","key":"10.1016\/j.bmc.2025.118521_bb0060","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1021\/acs.jmedchem.2c01159","article-title":"Blocking non-enzymatic functions by PROTAC-mediated targeted protein degradation","volume":"65","author":"Sun","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114838","article-title":"A bibliometric analysis of PROTAC from 2001 to 2021","volume":"244","author":"Li","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118521_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.bmc.2025.118521_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","article-title":"Development of targeted protein degradation therapeutics","volume":"15","author":"Chamberlain","year":"2019","journal-title":"Nat Chem Biol"},{"issue":"9","key":"10.1016\/j.bmc.2025.118521_bb0080","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1021\/acs.jmedchem.7b01655","article-title":"Chemically induced degradation of anaplastic lymphoma kinase (ALK)","volume":"61","author":"Powell","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115911","article-title":"Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques","volume":"262","author":"Chen","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116827","article-title":"Discovery of orally bioavailable ALK PROTACs based ceritinib against ALK positive cancers","volume":"279","author":"Zhou","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106556","article-title":"Discovery of a miniaturized PROTAC with potent activity and high selectivity","volume":"136","author":"Gong","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113335","article-title":"Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib","volume":"217","author":"Ren","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"13","key":"10.1016\/j.bmc.2025.118521_bb0105","doi-asserted-by":"crossref","first-page":"9120","DOI":"10.1021\/acs.jmedchem.1c00270","article-title":"Development of Alectinib-based PROTACs as novel potent degraders of anaplastic lymphoma kinase (ALK)","volume":"64","author":"Xie","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115082","article-title":"Discovery of the GSH responsive \u201cY-PROTACs\u201d targeting ALK and CDK4\/6 as a potential treatment for cancer","volume":"248","author":"Wang","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2025.118521_bb0115","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1021\/acs.jmedchem.4c00208","article-title":"Distinct amino acid-based PROTACs target oncogenic kinases for degradation in non-small cell lung Cancer (NSCLC)","volume":"67","author":"Zhang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112993","article-title":"PROTACs to address the challenges facing small molecule inhibitors","volume":"210","author":"Mart\u00edn-Acosta","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118521_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bcp.2016.07.017","article-title":"New strategy for renal fibrosis: targeting Smad3 proteins for ubiquitination and degradation","volume":"116","author":"Wang","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.bmc.2025.118521_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/cn500054n","article-title":"The first CNS-active Carborane: a novel P2X7 receptor antagonist with antidepressant activity","volume":"5","author":"Wilkinson","year":"2014","journal-title":"ACS Chem Neurosci"},{"issue":"16","key":"10.1016\/j.bmc.2025.118521_bb0135","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1080\/00397910008087435","article-title":"Synthesis of (Trifluoromethylthio) cubanes","volume":"27","author":"Munavalli","year":"1997","journal-title":"Synth Commun"},{"issue":"3","key":"10.1016\/j.bmc.2025.118521_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cmdc.201100559","article-title":"Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs","volume":"7","author":"Joubert","year":"2012","journal-title":"ChemMedChem"},{"issue":"28","key":"10.1016\/j.bmc.2025.118521_bb0145","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1039\/C9OB01238A","article-title":"The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement","volume":"17","author":"Houston","year":"2019","journal-title":"Org Biomol Chem"},{"issue":"12","key":"10.1016\/j.bmc.2025.118521_bb0150","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/jp511756v","article-title":"The thermochemistry of cubane 50 years after its synthesis: a high-level theoretical study of cubane and its derivatives","volume":"119","author":"Agapito","year":"2015","journal-title":"J Phys Chem A"},{"issue":"7","key":"10.1016\/j.bmc.2025.118521_bb0155","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.bmc.2003.12.045","article-title":"Synthesis and biological evaluation of pentacyclo[5.4.0.02,6.03,10.05,9]undecane derivatives as potential therapeutic agents in Parkinson\u2019s disease","volume":"12","author":"Geldenhuys","year":"2004","journal-title":"Bioorg Med Chem"},{"issue":"3620","key":"10.1016\/j.bmc.2025.118521_bb0160","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-Adamantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.bmc.2025.118521_bb0165","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1021\/acs.jmedchem.0c00746","article-title":"Nonclassical phenyl bioisosteres as effective replacements in a series of novel open-source antimalarials","volume":"63","author":"Tse","year":"2020","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2025.118521_bb0170","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cmdc.201200208","article-title":"Synthesis and biological evaluation of adenosines with heterobicyclic and polycyclic N6-substituents as adenosine A1 receptor agonists","volume":"7","author":"Gosling","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2025.118521_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117089","article-title":"Identification of inhibitors targeting the FLT3-ITD mutation through 4D-QSAR, in vitro, and in silico","volume":"282","author":"Chu","year":"2025","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118521_bb0180","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/acs.jcim.9b01120","article-title":"Deep Generative Models for 3D Linker Design","volume":"60","author":"Imrie","year":"2020","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10.1016\/j.bmc.2025.118521_bb0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s42256-024-00815-9","article-title":"Equivariant 3D-conditional diffusion model for molecular linker design","volume":"6","author":"Igashov","year":"2024","journal-title":"Nat Mach Intellig"},{"issue":"23","key":"10.1016\/j.bmc.2025.118521_bb0190","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1021\/acs.jcim.2c00982","article-title":"DRlinker: deep reinforcement learning for optimization in fragment linking design","volume":"62","author":"Tan","year":"2022","journal-title":"J Chem Inf Model"},{"issue":"10","key":"10.1016\/j.bmc.2025.118521_bb0195","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1021\/acs.jcim.0c00589","article-title":"PRosettaC: Rosetta based Modeling of PROTAC mediated ternary complexes","volume":"60","author":"Zaidman","year":"2020","journal-title":"J Chem Inf Model"},{"issue":"21","key":"10.1016\/j.bmc.2025.118521_bb0200","doi-asserted-by":"crossref","first-page":"16271","DOI":"10.1021\/acs.jmedchem.1c01576","article-title":"Integrative Modeling of PROTAC-mediated ternary complexes","volume":"64","author":"Weng","year":"2021","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2025.118521_bb0205","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1021\/acs.jmedchem.1c02155","article-title":"In silico Modeling and scoring of PROTAC-mediated ternary complex poses","volume":"65","author":"Liao","year":"2022","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118521_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"issue":"3","key":"10.1016\/j.bmc.2025.118521_bb0215","first-page":"435","article-title":"New additions to the ClusPro server motivated by CAPRI, proteins: structure, function, and bioinformatics","volume":"85","author":"Vajda","year":"2017"},{"issue":"12","key":"10.1016\/j.bmc.2025.118521_bb0220","first-page":"2159","article-title":"How good is automated protein docking?","volume":"81","author":"Kozakov","year":"2013"},{"issue":"13","key":"10.1016\/j.bmc.2025.118521_bb0225","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"13","key":"10.1016\/j.bmc.2025.118521_bb0230","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/acs.jmedchem.1c00373","article-title":"Discovery of a Brigatinib degrader SIAIS164018 with destroying metastasis-related oncoproteins and a reshuffling Kinome profile","volume":"64","author":"Ren","year":"2021","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118521_bb0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2025.118521_bb0240","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3184\/174751917X15125690124264","article-title":"Functionalised Cookson\u2019s diketones in chlorosulfonic acid: towards polysubstityted D3-trishomocybanes","volume":"12","author":"Zhyhadlo","year":"2017","journal-title":"J Chem Res"},{"issue":"19","key":"10.1016\/j.bmc.2025.118521_bb0245","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.bmcl.2012.08.046","article-title":"A \u03c31 receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ols (AHDs)","volume":"22","author":"Banister","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10.1016\/j.bmc.2025.118521_bb0250","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/jo00870a032","article-title":"Syntheses of the pentacyclo[6.3.0.02,6.03,10.05,9]undecyl (trishomocubyl) and tetracyclo[6.3.0.04,11.05,9]undeca-2,6-dienyl (homohypostrophenyl) systems","volume":"41","author":"Smith","year":"1976","journal-title":"J Organ Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118521_bb0255","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Mol Graph Model"},{"issue":"1","key":"10.1016\/j.bmc.2025.118521_bb0260","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"10.1016\/j.bmc.2025.118521_bb0265","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"issue":"30","key":"10.1016\/j.bmc.2025.118521_bb0270","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1021\/jp8001614","article-title":"Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations","volume":"112","author":"Joung","year":"2008","journal-title":"J Phys Chem B"},{"issue":"7","key":"10.1016\/j.bmc.2025.118521_bb0275","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J Chem Theory Comput"},{"issue":"25","key":"10.1016\/j.bmc.2025.118521_bb0280","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/jcc.25382","article-title":"Parallelization of CPPTRAJ enables large scale analysis of molecular dynamics trajectory data","volume":"39","author":"Roe","year":"2018","journal-title":"J Comput Chem"},{"issue":"9","key":"10.1016\/j.bmc.2025.118521_bb0285","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"10.1016\/j.bmc.2025.118521_bb0290","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:25:08Z","timestamp":1771655108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":58,"alternative-id":["S0968089625004638"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118521","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel PROTACs with polyhedral alkanes as linkers for enhanced ALK degradation in drug-resistant NSCLC","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118521"}}